News | Pediatric Imaging | May 29, 2018

New Ultrasound Guidelines Reliably Identify Children Who Should be Biopsied for Thyroid Cancer

Study finds American College of Radiology guidelines effectively distinguish likely benign tumors from those that are more likely to be malignant

New Ultrasound Guidelines Reliably Identify Children Who Should be Biopsied for Thyroid Cancer

Image courtesy of Loyola Medicine

May 29, 2018 — A Loyola Medicine study has found that new ultrasound guidelines can reliably identify pediatric patients who should be biopsied for thyroid cancer.

The study by radiologist Jennifer Lim-Dunham, M.D., and colleagues was presented May 18 during the Society for Pediatric Radiology's annual meeting in Nashville.

Thyroid cancer is a common cause of cancer in teenagers, and the incidence is increasing for reasons that are unclear. Adolescents have a 10-fold greater incidence than younger children, and the disease is five times more common in girls than boys.

The thyroid is a butterfly-shaped gland at the base of the neck that secretes hormones needed for regulation of growth, development and metabolism. Cancer may occur within lumps in the thyroid called nodules.  

Thyroid nodules typically are found during routine physical exams or on imaging tests such as computed tomography (CT) scans done for other reasons. A definitive diagnosis requires a percutaneous fine-needle aspiration biopsy – a minimally invasive procedure in which a physician uses a very small needle to withdraw cells from the nodule. The cells are sent to a pathologist, who makes the diagnosis.

Since most nodules are benign, not all of them require biopsy. Ultrasound exams are used to identify those nodules that look suspicious enough to require biopsy. In 2017, the American College of Radiology (ACR) released a system for grading nodules on a 1 to 5 scale, with 1 being benign and 5 being highly suspicious of cancer. The grades are based on ultrasound features, such as how white or black the nodule appears (echogenicity), whether the edges of the nodule are jagged or smooth and whether there are white dots inside the nodule (echogenic foci).

In the Loyola study, two radiologists used the ACR system to retrospectively grade 74 thyroid nodules from 62 pediatric patients. The ACR grading system proved to be accurate and reproducible. For every one unit increase in the 1-to-5 ACR scale, nodules were 2.63 times more likely to have a malignant diagnosis confirmed by biopsy or surgery.

The findings should reassure physicians and parents that the ACR system can be reliably used to differentiate between thyroid nodules in children that require biopsy and those that do not, Lim-Dunham said. An earlier study led by Lim-Dunham found that a different set of thyroid nodule ultrasound guidelines from the American Thyroid Association also are reliable in children.

The new study is titled "Malignancy Risk Stratification of Pediatric Thyroid Nodules Using ACR Thyroid Imaging, Reporting and Data System (ACR TI-RADS)."

In addition to Lim-Dunham, other co-authors are Iclal Erdem Toslak, M.D., Michael Reiter, M.D., and Brendan Martin, Ph.D.

For more information: www.loyolamedicine.org

Related Content

Amazon Comprehend Medical Brings Medical Language Processing to Healthcare
News | Artificial Intelligence | February 15, 2019
Amazon recently announced Amazon Comprehend Medical, a new HIPAA-eligible machine learning service that allows...
Videos | Radiation Therapy | February 15, 2019
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the
Fujifilm Exhibits Enterprise Imaging Solutions and Artificial Intelligence Initiative at HIMSS 2019
News | Enterprise Imaging | February 15, 2019
Fujifilm Medical Systems U.S.A. Inc. and Fujifilm SonoSite Inc. showcased their enterprise imaging and informatics...
Micro-Ultrasound and Artificial Intelligence Combining to Detect Prostate Cancer
News | Prostate Cancer | February 12, 2019
Cambridge Consultants has partnered with Exact Imaging, makers of the ExactVu micro-ultrasound platform, as the two...
An example of Philips' TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal.

An example of Philips' TrueVue technology, which offers photo-realistic rendering and the ability to change the location of the lighting source on 3-D ultrasound images. In this example of two Amplazer transcatheter septal occluder devices in the heart, the operator demonstrating the product was able to push the lighting source behind the devices into the other chamber of the heart. This illuminated a hole that was still present that the occluders did not seal. 

Feature | Ultrasound Imaging | February 07, 2019 | Dave Fornell, Editor
Here is a list of six key trends in ul...
Epiq Elite for Obstetrics and Gynecology delivers high image quality and lifelike 3-D scans

The Epiq Elite for Obstetrics & Gynecology. Image courtesy of Philips Healthcare.

Technology | Ultrasound Imaging | February 07, 2019
Philips announced the launch of the Epiq Elite ultrasound system, a new premium ultrasound that combines the latest...
Oxford University Hospitals Employs Barco Synergi for Multi-disciplinary Cancer Conferences
News | Oncology Diagnostics | February 06, 2019
Oxford University Hospitals (OUH) is trialing clinical collaboration technology from Barco for its Multi-disciplinary...
ASE Releases Guidelines for Transesophageal Echo in Congenital Heart Disease
News | Ultrasound Transesophageal echo (TEE) | February 05, 2019
February 5, 2019 – The American Society of Echocardiography (ASE) released a new document that provides a comprehensi
Study Assesses Risk of MRI Exams for Patients With Tattoos
News | Magnetic Resonance Imaging (MRI) | February 01, 2019
A new European study concluded that magnetic resonance imaging (MRI) exams pose little risk for people with tattoos,...
Stereotactic Radiotherapy Improves Long-Term Survival in Stage-IV Cancers
News | Stereotactic Body Radiation Therapy (SBRT) | January 31, 2019
The first report from a phase II, multi-center clinical trial indicates stereotactic radiation can extend long-term...